| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/04/2013 | WO2013045400A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 04/04/2013 | WO2013045068A1 Compositions comprising phytoestrogens receptor beta agonists and dietary fibres for chemopreventive treatment of sporadic adenomatous polyposis |
| 04/04/2013 | WO2013045028A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | WO2013044811A1 Gemcitabine amide derivative and preparation method and use thereof |
| 04/04/2013 | WO2013044596A1 Kidney-type glutaminase inhibitor and preparation method and use thereof |
| 04/04/2013 | WO2013044341A1 Nanoparticulate magnetic material for thermal applications |
| 04/04/2013 | WO2013019058A3 Pharmaceutical composition for inhibiting cancer recurrence or metastasis |
| 04/04/2013 | WO2013009790A3 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 04/04/2013 | WO2013004842A3 Antibody variants and uses thereof |
| 04/04/2013 | WO2012177844A3 Substituted imidazopyridinyl-aminopyridine compounds |
| 04/04/2013 | WO2012177100A3 Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent |
| 04/04/2013 | WO2012174203A3 Methods and kits for the detection and treatment of recurring prostate cancer |
| 04/04/2013 | WO2012173987A3 Methods of treatment using a bcat1 inhibitor |
| 04/04/2013 | WO2012171024A3 Enzyme directed assembly of particle theranostics |
| 04/04/2013 | WO2012170742A3 Treatment and prevention of cancer with hmgb1 antagonists |
| 04/04/2013 | WO2012154885A3 Carbonic anhydrase targeting agents and methods of using same |
| 04/04/2013 | WO2012142575A3 Monomeric trioxane amide sulfur compounds |
| 04/04/2013 | WO2012138694A3 Compositions comprising saccharide binding moieties and methods for targeted therapy |
| 04/04/2013 | WO2012074842A3 Compositions and methods for treating neoplasia |
| 04/04/2013 | WO2011020115A3 Methods of treating cancer using growth factor retargeted endopeptidases |
| 04/04/2013 | US20130085172 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | US20130085164 Imidazole Derivatives |
| 04/04/2013 | US20130085148 Pyridine Derivatives |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084298 Novel anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof |
| 04/04/2013 | US20130084297 Anti-ErbB3 Antibodies and Uses Thereof |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | CA2850610A1 Sphingosine analogs, compositions, and methods related thereto |
| 04/04/2013 | CA2850570A1 Methods of treating cancer |
| 04/04/2013 | CA2850566A1 Processes for making compounds useful as inhibitors of atr kinase |
| 04/04/2013 | CA2850564A1 Compounds useful as inhibitors of atr kinase |
| 04/04/2013 | CA2850542A1 Therapeutic peptides |
| 04/04/2013 | CA2850541A1 Nitrogen mustard derivatives |
| 04/04/2013 | CA2850508A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| 04/04/2013 | CA2850491A1 Treating pancreatic cancer and non-small cell lung cancer with atr inhibitors |
| 04/04/2013 | CA2850469A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | CA2850330A1 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer) |
| 04/04/2013 | CA2850322A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | CA2850261A1 Biological materials related to c-met |
| 04/04/2013 | CA2850196A1 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide-3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate |
| 04/04/2013 | CA2850194A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | CA2849999A1 Macrocyclic flt3 kinase inhibitors |
| 04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
| 04/04/2013 | CA2849820A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist |
| 04/04/2013 | CA2849765A1 Hybrid constant regions |
| 04/04/2013 | CA2849746A1 Anti-icam-1 antibodies to treat multiple-myeloma related disorders |
| 04/04/2013 | CA2848154A1 Novel heterocyclic derivatives and their uses |
| 04/04/2013 | CA2848065A1 Method of treating mucoepidermoid carcinoma |
| 04/04/2013 | CA2847921A1 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 04/04/2013 | CA2846200A1 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 04/04/2013 | CA2845191A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 04/03/2013 | EP2574630A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/03/2013 | EP2574629A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/03/2013 | EP2574623A2 Peptide vaccines for cancers expressing tumor-associated antigens |
| 04/03/2013 | EP2574347A2 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 04/03/2013 | EP2574341A1 Effective treatment of tumors and cancer with triciribine and related compounds |
| 04/03/2013 | EP2574340A2 Combination comprising a pyrimidylaminobenzamide compound and a THR315LLEe kinase inhibitor |
| 04/03/2013 | EP2574334A1 Bendamustine pharmaceutical compositions for lyophilisation |
| 04/03/2013 | EP2574170A2 Immunostimulatory and vaccine compositions |
| 04/03/2013 | CN1622958B Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN103025761A Humanized anti-interleukin 3 receptor alpha chain antibodies |
| 04/03/2013 | CN103025760A Humanized EGFR antibodies |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025753A Crystalline ezatiostat hydrochloride ansolvate |
| 04/03/2013 | CN103025741A Crystalline forms of kinase inhibitors |
| 04/03/2013 | CN103025738A Furopyridine compounds and uses thereof |
| 04/03/2013 | CN103025725A Hetero ring compound |
| 04/03/2013 | CN103025384A Materials and methods related to modulation of mismatch repair and genomic stability by mir-155 |
| 04/03/2013 | CN103025343A Sustained-release formulation |
| 04/03/2013 | CN103014090A Method for extracting bis-benzene oxepin-11(6H) keto-1, 10-dihydroxy, 3-methyl-7, 8-dimethoxy from Moller bacteria |
| 04/03/2013 | CN103013927A Application of anti-cellular-prion-protein monoclonal antibody in preparing antitumor drugs |
| 04/03/2013 | CN103013754A Method for brewing health-care wine |
| 04/03/2013 | CN103012778A Water-soluble taxol polymer with tumor actively-targeted property |
| 04/03/2013 | CN103012771A Acid-sensitive splitting-decomposable connecting unit and application thereof |
| 04/03/2013 | CN103012672A 5-fluorouracil copolymer with anti-tumor activity and preparation method of 5-fluorouracil copolymer |
| 04/03/2013 | CN103012671A Coumarin macromolecule polymer with anti-tumor activity and preparation method of coumarin macromolecule polymer |
| 04/03/2013 | CN103012618A Preparation method of switch type NO procedural donor |
| 04/03/2013 | CN103012590A Anti-CD20 monoclonal antibody, preparation method and application thereof |
| 04/03/2013 | CN103012589A Human anti-vascular endothelial cell growth factor antibody and application thereof |
| 04/03/2013 | CN103012588A Targeted therapy of tumors by using McAb capable of neutralizing VEGFA biological activity |
| 04/03/2013 | CN103012587A Preparation, identification and application of monoclonal antibody of specific human lung resisting specific X protein |
| 04/03/2013 | CN103012586A Recombinant antibodies and fragments recognising ganglioside N-glycolyl-GM3 and use thereof in the diagnosis and treatment of tumours |
| 04/03/2013 | CN103012566A Non-phosphorylation ligand combined with Grb7 protein SH2 structural domain and pharmaceutical application thereof |
| 04/03/2013 | CN103012562A Dual-targeting D-configuration polypeptides and drug delivery system thereof |
| 04/03/2013 | CN103012561A Small peptide for tumor targeted diagnosis |
| 04/03/2013 | CN103012559A Peptaibol compound and application thereof |
| 04/03/2013 | CN103012540A 22-drop-6-hydroxystigmast-3,22-O-dimethyloxime ether and 22-drop-6-oximido-stigmast-3,22-O-dimethyloxime ether and application thereof to preparation of antitumor drugs |
| 04/03/2013 | CN103012530A Preparation method of compound endecaphyllacins B and application thereof in preparation of anti-tumor drugs |
| 04/03/2013 | CN103012508A Tartary buckwheat phenylpropanoid glycoside compound and preparation method and application thereof |
| 04/03/2013 | CN103012465A Diphenyltin coordination compound and preparation method and application thereof |
| 04/03/2013 | CN103012428A 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
| 04/03/2013 | CN103012421A Isoquinoline drug, its preparation and application |
| 04/03/2013 | CN103012417A Carbazole alkaloids in clausena plants, medicine composition with carbazole alkaloids as anti-tumor active component, and preparation method and application of carbazole alkaloids |
| 04/03/2013 | CN103012410A [1,2,4] triazole [4,3-b] sym-tetrazine derivation compound and preparation method thereof |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012405A New adenine type compound |
| 04/03/2013 | CN103012401A Preparation method and application of anthraquinone polypyridine ligand and ruthenium-anthraquinone complex |
| 04/03/2013 | CN103012399A 7-oxopyridinopyrimidine compound as well as medicinal composition and application thereof |